Biotronik Inc.
$4.5M 10,399 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Daiichi Sankyo Company LTD
Daiichi Sankyo Company LTD reported $4,554,987.75 across General Payments, Research, and Ownership to 51 physicians and teaching hospitals across 261 transactions.
- $4.6M Top quartile payer
- All-tracks total
- 261 Above-median volume
- Transactions
- 51 Below-median reach
- Recipients
- +$109.3K
- General Payments vs PY2023
Daiichi Sankyo Company LTD reported $4,554,987.75 across all CMS Open Payments tracks (General + Research + Ownership) to 51 physicians and teaching hospitals in Program Year 2024 - ranking #288 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $316,436.00, averaging $89.3K per recipient.
How Daiichi Sankyo Company LTD's $4.6M all-tracks total breaks down
Daiichi Sankyo Company LTD's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
31/100
Total payments
D
52/100
Transaction volume
F
12/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer daiichi-sankyo-company-ltd Daiichi Sankyo Company LTD
$4.6M · #288/1,925 · 0.0% industry · PY2024
- TOT $4.6M
- RANK #288
- SHARE 0.0%
- TXN 261
- RCP 51
- CAT 4
- GEN $316.4K
- ΔGEN +$109.3K
- TOP1 20.5%
- PY 2024
Volume peers
Nearest volume peer: Biotronik Inc. ($4.5M)
Daiichi Sankyo Company LTD sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Daiichi Sankyo Company LTD's CMS-reported General Payments increased by $109.3K (+52.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: DAIICHI SANKYO COMPANY LTDPY2023: DAIICHI SANKYO COMPANY LTDPY2024: Daiichi Sankyo Company LTD. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $207,171.43
- PY2024
- $316,436.00
What the Data Shows for Daiichi Sankyo Company LTD
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Daiichi Sankyo Company LTD, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 4 general-payment categories charted below, "Royalty or License" is the largest at $159.0K across 7 transactions, 50.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Royalty or License" leads Daiichi Sankyo Company LTD's 4-category general-payment breakdown at $159.0K, 50.2% of the reported total.
Daiichi Sankyo Company LTD reports 4 general-payment categories - the top three are Royalty or License (50.2%), Consulting Fee (27.4%), and Travel and Lodging (21.9%). The remaining 1 category make up 0.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Daiichi Sankyo Company LTD divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $159.0K | 7 | 50.2% |
| Consulting Fee | $86.6K | 14 | 27.4% |
| Travel and Lodging | $69.3K | 19 | 21.9% |
| Food and Beverage | $1.5K | 11 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $235,839.22 (74.5%) of $316,436.00 in this company's General Payments records across 15 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Daiichi Sankyo Company LTD
The five named recipients with the highest reported General Payments from this company
- 1
Memorial Hospital For Cancer And All
$65,000.00 across 2 reported transactions
- 2
Hospital Of The Univ Of Penna
$56,000.00 across 2 reported transactions
- 3
Erika Hamilton
$46,438.26 across 8 reported transactions
- 4
Komal Jhaveri
$38,400.96 across 9 reported transactions
- 5
Chi St Lukes Health Baylor Med Ctr
$30,000.00 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Daiichi Sankyo Company LTD ranks #288 of 1,925 by total payments (top 15% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #923 of 1,838 by HHI (top 50% most concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Tyber Medical, LLC : $95.0K total payments, HHI 1309
- Streck LLC : $9.8K total payments, HHI 1302
- NanoHive Medical LLC : $27.9K total payments, HHI 1299
- Curiteva, Inc. : $373.8K total payments, HHI 1298
- Thea Pharma Inc. : $512.0K total payments, HHI 1298
- Whip Mix Corporation : $1.5K total payments, HHI 1295
- Daiichi Sankyo Company LTD (this company) : $316.4K total payments, HHI 1293
- Collagen Matrix, Inc : $83.9K total payments, HHI 1290
- Nvision Biomedical Technologies, Inc. : $80.7K total payments, HHI 1290
- IMPLANET America, Inc. : $12.6K total payments, HHI 1277
- Aero US Inc : $19.3K total payments, HHI 1269
- Astellas Pharma Europe Ltd : $523.2K total payments, HHI 1263
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Daiichi Sankyo Company LTD's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Daiichi Sankyo Company LTD.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Daiichi Sankyo Company LTD.
Showing 6 of 1,924 companies with CMS-reported payment data.
Ipsen Pharma SAS
$4.6M 54 recipients
Compare payment profiles
bluebird bio, Inc.
$4.5M 229 recipients
Compare payment profiles
Novocure Inc.
$4.5M 3,615 recipients
Compare payment profiles
Octapharma USA, Inc.
$4.4M 5,207 recipients
Compare payment profiles
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4.4M 161,040 recipients
Compare payment profiles
Put this to use
Daiichi Sankyo Company LTD ranks #288 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Daiichi Sankyo Company LTD sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Daiichi Sankyo Company LTD. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.